by EDITORIAL | Mar 30, 2026 | Articles, FDA and Government, GLP-1, Government and FDA, Latest News, PEMF THERAPY, Therapy
There is a quiet failure mode built into the modern weight loss revolution, and almost no one discusses it openly. Millions of people are successfully shedding pounds using GLP-1 agonists like Ozempic and Wegovy, only to discover a terrifying secondary effect: up to...
by EDITORIAL | Sep 30, 2025 | Articles, FDA and Government, Government and FDA, Latest News, Osteoporosis
# PEMF and Bone Health: Revolutionary Osteoporosis Treatment The silent epidemic of osteoporosis affects over 200 million people worldwide, with fractures occurring every three seconds. As our population ages and the limitations of traditional drug therapies become...
by EDITORIAL | Aug 3, 2023 | Articles, PEMF THERAPY, Therapy
Osteoporosis, a disease characterized by low bone mass and fragile bone strength, results in high morbidity and mortality. Patients diagnosed with osteoporosis have a significantly increased risk of fragility fractures. Various anabolic and antiresorptive therapies...
by EDITORIAL | Aug 3, 2023 | Articles, PEMF THERAPY, Therapy
Osteoporosis, a disease characterized by low bone mass and fragile bone strength, results in high morbidity and mortality. Patients diagnosed with osteoporosis have a significantly increased risk of fragility fractures. Various anabolic and antiresorptive therapies...
